AIRO Neurooncology Group

The neurooncology group of Italian association of radiation oncology AIRO

[AIRO Neurooncology Group @AIRO_CNS]

@Ithurts42 19

[ISRSy @ISRSy]

📢Join us THIS WEEK for the next #ISRSWebinar:
"SBRT FOR OLIGOMETASTASES: PAST, PRESENT, FUTURE”

🗓️ Thu, 26 Jan 2023, 14:00 CET
🥼 David PALMA, MD, PHD @drdavidpalma
Prof & #RadOnc, @WesternU
👉 REGISTER: https://t.co/lCIWCXaRgs

[Journal of Neuro-Oncology @JNeurooncol]

PostOp hypofractionated stereotactic irradiation can be delivered with 25–30 Gy in 5 fractions with efficacy in excess of 82% & no significant toxicity when the dose to ‘brain−GTV’ does not exceed 20 cm3 @UZH_en @UZH_ch @ksaarau @ASTRO_org @ACRORadOnc
https://t.co/IWDdbnZBvo

[ESMO Open @ESMO_Open]

How we treat primary central nervous system lymphoma - #PCNSL - which patients should be treated with HDC/ASCT? https://t.co/YunDvzxOnx @EANOassociation

[EANO @EANOassociation]

First-in-human phase I study shows safety and potential efficacy of oral TGF-βR1 inhibitor LY3200882 for the treatment of recurrent #glioma with some PRs per RANO criteria. #btsm

[AIRO Neurooncology Group @AIRO_CNS]

Venerdì 1 ottobre ore 15:30: proseguono i venerdì di neuro-oncologia! Questa settimana IMMUNOTERAPIA E RADIOTERAPIA NEL TRATTAMENTO DELLE METASTASI DA NSCLC. Non mancate!
#airocns #webinar

[EANO @EANOassociation]

🎯It’s tomorrow! Join us at #EANO2021 virtual. Enjoy limitless learning with 2 days full of scientific sessions, discussions and networking events in #Neurosurgery #NeuroOncology #braintumor #RadiationTherapy #Immunotherapy #PrimaryBrainTumors #btsm @OncoAlert @OncLive

[AIRO Neurooncology Group @AIRO_CNS]

Oggi ore 15.30: immunoterapia e radioterapia nel trattamento delle metastasi da melanoma! Non mancate!
#airocns

[AIRO Neurooncology Group @AIRO_CNS]

Friday September 24th
Next AIRO_CNS Webinar

Vi aspettiamo numerosi per discutere su #mets encefalo #SRS #Radiotherapy #immunotherapy #radonc

[Journal of Neuro-Oncology @JNeurooncol]

Learn more here about interactions among mitochondrial proteins altered in #glioblastoma @NSTumorSection #cancer #laboratory #research https://t.co/Eg8SaXcGtN

[Journal of Neuro-Oncology @JNeurooncol]

Although a #osimertinib/#bevacizumab combination was marginally effective in most #glioblastoma patients with #EGFR amplification and #EGFRvIII mutation, a subgroup experienced a long-lasting meaningful benefit. @AndresFCardonaZ @ogarrieta
https://t.co/UiIgugXEBN

[Filippo Alongi @alongi_filippo]

CORSO @AIRO80327989 SUI TRATTAMENTI STEREOTASSICI ABLATIVI #SBRT #SABR #oligomets #RadOnc #radonc : STATO DELL'ARTE, INDICAZIONI ED IMPLICAZIONI NELLA PRATICA CLINICA
Webinar ECM. Iscrivetevi qui: 👉 https://t.co/YfLwNwvC0N

[Joost Verhoeff @joostverhoeff]

Morphological changes after cranial fractionated photon radiotherapy. Steven Nagtegaal et al. @ctRO_journal 2021.

White matter and grey matter volume loss rates ranging from 5.3 to 15.3% per 30 Gy.

@UMCUtrecht @Szabolcs_David @mje_zandvoort

https://t.co/nsg8ysu0o1 #openaccess

[Journal of Neuro-Oncology @JNeurooncol]

Check out this analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma @NSTumorSection #brain #cancer https://t.co/jiC4cibiX8

[valentinapinzi MD, PhD @valentinapinzi]

@AIRO_CNS @AIRO80327989
📯Next scheduled event focused on #radionecrosis #radonc #neurotwitter
🧠 🧐
🔜 📌Vi aspettiamo venerdì 10 settembre 🔜

[Brain Metastasis Program @ MSK @BrainMets_MSK]

#Leptomeningeal #metastasis often requires CSF shunting- but pt selection+goals essential. In @JNeurooncol we ID key outcome determinants: #brainmet burden, KPS++ to help guide rx decisions @MSKNeurosurgery @Dr_N_Moss @evanbanderMD @MelissaYuanMD @Anne_S_Reiner @MSKBiostats

[AIRO Neurooncology Group @AIRO_CNS]

Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences

https://t.co/wxZJD5HLuw

[AIRO Neurooncology Group @AIRO_CNS]

Long-term outcomes of spinal SBRT. Is it important to select the treatment time?

https://t.co/eOvV5E4LN9

[AIRO Neurooncology Group @AIRO_CNS]

Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis

https://t.co/qnQqa13G7G

[AIRO Neurooncology Group @AIRO_CNS]

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases

https://t.co/7KWJMoOAaY